Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Antibodies
Filter     Order     Display # 
Date Item Title
06 Jun 2007 Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
06 Jun 2007 Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
06 Jun 2007 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
05 Jun 2007 Investigational cancer drug Pertuzumab shows promising results in advanced breast cancer when combined with Herceptin
05 Jun 2007 ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
04 Jun 2007 Patients Who Took Investigational Melanoma Compound CP-675,206 Showed Favorable Survival Outcomes, Pfizer Says
04 Jun 2007 Genentech Provides Update on Pipeline Agents at The American Society of Clinical Oncology Meeting
04 Jun 2007 Genmab's HuMax-EGFr shows broad potential in cancer treatment
03 Jun 2007 Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients with Previously Untreated Advanced Kidney Cancer
03 Jun 2007 Results of VEGF trap (aflibercept) highlighted at ASCO 2007 annual meeting
01 Jun 2007 Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma
01 Jun 2007 Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
31 May 2007 BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
31 May 2007 Human Genome Sciences and GlaxoSmithKline initiate second phase 3 clinical trial of LymphoStat-B(R) in systemic lupus erythematosus
26 May 2007 Amgen to Appeal CHMP Opinion on Vectibix(TM) (Panitumumab)
25 May 2007 Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
25 May 2007 MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
25 May 2007 Viventia Biotech Inc. Reports Final Vicinium(TM) Phase I/II Bladder Cancer Data at the American Urological Association Annual Meeting
24 May 2007 Morphotek Receives Protocol Approval from German Regulatory Authority for Phase II Trial Site Selections in Heidelberg and Frankfurt
23 May 2007 Peptech enters Phase I clinical trial of PN0621
23 May 2007 PDL BioPharma Announces Long-Term Nuvion(R) Data Presented at 2007 Digestive Disease Week
23 May 2007 UCB Presents Long-Term CIMZIAâ„¢ Data in Crohn's Disease
23 May 2007 Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab(TM)
22 May 2007 Genmab's Humax-Hepc Prevents Hepatitis C Virus Infection In Animal Model
22 May 2007 Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
22 May 2007 Morphotek Signs Development and Clinical Supply Agreement with CMC Biopharmaceuticals A/S for Therapeutic Antibody to Treat Melanoma
18 May 2007 Millennium Resumes Clinical Program for MLN0002
17 May 2007 Organon and Medarex announce biotherapeutics development agreement
17 May 2007 Peregrine Pharmaceuticals to Initiate New Bavituximab HCV Clinical Trial in Patients Co-Infected With HIV
10 May 2007 Vegf Trap-Eye Phase 2 Wet Amd Results Reported At Arvo Annual Meeting
09 May 2007 MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
08 May 2007 Abbott Seeks U.S. and E.U. Regulatory Approvals for HUMIRA(R) (Adalimumab) as a Treatment for Juvenile Rheumatoid Arthritis
08 May 2007 Biolex Therapeutics Announces Agreement With Genmab For New Class Of Antibodies
08 May 2007 Peptech and Evogenix Merge to Form Antibody Powerhouse
07 May 2007 Affitech Signs Antibody Research and Licensing Agreement with Roche
05 May 2007 Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
05 May 2007 Viragen Shifts Development Focus for Anti-Cancer Products
04 May 2007 Herceptin approved in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2 and hormone receptor-co-positive metastatic breast cancer
04 May 2007 Data Presented at the American Academy on Neurology's Annual Meeting Provide Update on Utilization and Safety of Tysabry(R) in Patients with Multiple Sclerosis
03 May 2007 Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
03 May 2007 ThromboGenics Announces Progress With its Pre-Clinical and Clinical Programs
03 May 2007 Y's Therapeutics Initiates Phase II Trial With YSPSL in Liver Transplant Patients for Prevention of Ischemic Reperfusion (I/R) Injury
02 May 2007 Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
02 May 2007 Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
01 May 2007 Dr. Reddy's launches Reditux(TM) Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
01 May 2007 Final Vectibix(TM) Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published
28 Apr 2007 Abbott's HUMIRA(R) (adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease
28 Apr 2007 CHMP Adopts Positive Opinion For Alexion's Soliris(TM) In Europe
27 Apr 2007 PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study in Intravenous Steroid-Refractory Ulcerative Colitis
27 Apr 2007 Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>
Results 601 - 650 of 1155

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics